Normal Saline Versus Betadine Use to Reduce the Incidence of Wound Infection in Cesarean Section
1 other identifier
interventional
300
1 country
1
Brief Summary
This is a prospective randomized controlled study to the difference between using normal saline or betadine irrigation of wound prior to skin closure in reducing the incidence of wound infection after Cesarean section.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_2
Started Nov 2018
Shorter than P25 for phase_2
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 20, 2018
CompletedFirst Posted
Study publicly available on registry
October 31, 2018
CompletedStudy Start
First participant enrolled
November 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2019
CompletedOctober 31, 2018
October 1, 2018
6 months
October 20, 2018
October 29, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
incidence of cs scar infection
incidence of cs scar infection
2 to 6 weeks
Secondary Outcomes (1)
incidence of hematoma, seroma
2 to 6 weeks
Study Arms (3)
no irrigation group
NO INTERVENTIONnothing used for irrigation of cs scar
saline irrigation group
PLACEBO COMPARATORsaline used for irrigation the cs scar before closure
betadine irrigation group
EXPERIMENTALbetadine used for irrigation of cs scar
Interventions
irrigation the edges of the cs scar before closure
Eligibility Criteria
You may qualify if:
- Subjects candidate for the study will be 37 weeks' gestation
- require a cesarean section (elective or emergency).
You may not qualify if:
- Patients with allergy to iodine
- history of immunosuppressive drug use,
- gestationaldiabetes mellitus
- preeclampsia
- anemic patients
- ruptured of membranes
- feverish patients
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Kasr El Ainy
Cairo, 02, Egypt
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
fady salah, lecturer
Director
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- assistant prfessor
Study Record Dates
First Submitted
October 20, 2018
First Posted
October 31, 2018
Study Start
November 1, 2018
Primary Completion
May 1, 2019
Study Completion
June 1, 2019
Last Updated
October 31, 2018
Record last verified: 2018-10